# Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life

> **NCT02606149** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 123 (actual)

## Conditions studied

- Stage IV Lung Cancer

## Interventions

- **BEHAVIORAL:** Truthful information on chemotherapy risks
- **BEHAVIORAL:** Standard of information

## Key facts

- **NCT ID:** NCT02606149
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-15
- **Primary completion:** 2020-10-15
- **Final completion:** 2020-10-15
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02606149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02606149, "Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02606149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*